Sponsored by:

Nuclear Medicine: Page 9

Pilot(less) study: Drones can deliver medical isotopes
By Will Morton
Cargo drones carrying medical isotopes could become an integral part of radiopharmaceutical supply chains, according to research presented July 26 at the International Conference on Isotopes meeting in Saskatoon, Saskatchewan, Canada.
July 26, 2023
2023 07 27 00 06 1652 2023 07 27 Isotope Drone 20230727010009
New PET radiotracer shows promise in NETs
By Will Morton
An experimental PET radiotracer shows promise for detecting metastatic cancer lesions in patients with neuroendocrine tumors, according to a study published July 20 in the Journal of Nuclear Medicine.
July 25, 2023
2023 07 25 22 44 8931 2023 07 25 Pet Nets 20230725225340
Ramsoft and Miranda Medical to establish partnership
By AuntMinnie.com staff writers
PACS vendor RamSoft and imaging software developer Mirada Medical plan to partner on a radiation therapy treatment package.
July 24, 2023
2022 06 28 17 16 2885 Hands Shaking3 20230509203239
Clarity reaches 50% recruitment for SABRE trial
By AuntMinnie.com staff writers
Radiopharmaceutical developer Clarity Pharmaceuticals has reached 50% recruitment for its Phase II Copper-64 SAR-Bombesin in Biochemical REcurrence of Prostate Cancer (SABRE) trial.
July 23, 2023
2019 04 17 20 48 2514 Prostate 3 D 400
SNMMI launches AI challenge
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has launched a radiomics and machine-learning challenge, with the winner to receive a cash prize and certificate.
July 20, 2023
Ratio Therapeutics highlights first patient treated in FAPI PET trial
By AuntMinnie.com staff writers
Ratio Therapeutics, in collaboration with Lantheus and PharmaLogic, has dosed the first patient in a phase I study investigating a novel fibroblast activated protein inhibitor (FAPI)-targeted radiopharmaceutical for PET imaging.
July 19, 2023
2023 07 20 18 02 2249 Pharmaceutical Manufacturing Scientists 400
PET/CT scans predict outcomes in patients with thyroid cancer
By Will Morton
PET/CT scans in patients with advanced thyroid cancer can predict their response to lenvatinib just one week after they begin treatment -- much faster than contrast-enhanced CT (CECT) exams, according to researchers in Japan.
July 18, 2023
2023 07 19 19 04 6002 2023 07 19 Thyroid Pet 400
DOE Isotope Program adds manganese-54 to catalog
By AuntMinnie.com staff writers
The U.S. Department of Energy Isotope Program (DOE IP) has added manganese-54 (Mn-54) to its product catalog.
July 18, 2023
2018 04 24 20 24 4264 Isotope 400
New scheme proposed for diagnosing Alzheimer's disease
By Will Morton
Experts have drafted new diagnostic criteria for Alzheimer's disease to reflect recent advances in the field, according to a July 16 presentation delivered at an international conference.
July 17, 2023
2022 08 01 18 21 3281 Brain Amyloid Plaque Neuron 400
Canada grapples with shortage of SPECT agent
By Will Morton
Due to production delays, Canada is facing a shortage of dypyridamole -- an agent used in SPECT myocardial perfusion imaging (MPI) to diagnose coronary artery disease.
July 17, 2023
2017 04 03 18 01 52 418 Graph Arrow Down 400
How should patients manage Lu-PSMA-617 waste disposal?
By Will Morton
A medical physicist in Iowa has crunched the numbers and determined the safest approach for prostate cancer patients receiving Lu-PSMA-617 (Pluvicto) to dispose of their radioactive urine, according to a recent communication in the Journal of Nuclear Medicine.
July 16, 2023
2016 09 08 13 50 18 153 Radiation Symbol Circle 400
Is PSMA PET/CT cost-effective for primary staging?
By Will Morton
PET/CT scans in patients with prostate cancer may increase costs in Europe and the U.S., yet these costs may be reasonably low compared to the potential expenses of an inaccurate diagnosis, according to a recent study.
July 13, 2023
2019 04 17 20 48 2514 Prostate 3 D 400
Previous Page
Page 9 of 440
Next Page